Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Triterpenes | 4 | 2019 | 80 | 1.600 |
Why?
|
| Unfolded Protein Response | 3 | 2022 | 233 | 1.520 |
Why?
|
| Leptin | 5 | 2024 | 1599 | 1.490 |
Why?
|
| Anti-Obesity Agents | 3 | 2019 | 216 | 1.490 |
Why?
|
| Obesity | 16 | 2024 | 12742 | 1.470 |
Why?
|
| Fatty Liver | 5 | 2022 | 729 | 1.400 |
Why?
|
| Glucose | 10 | 2022 | 4396 | 1.250 |
Why?
|
| Endoplasmic Reticulum | 7 | 2013 | 1144 | 1.010 |
Why?
|
| Mice, Obese | 9 | 2022 | 424 | 0.990 |
Why?
|
| Insulin Resistance | 9 | 2022 | 3863 | 0.920 |
Why?
|
| Homeostasis | 9 | 2022 | 3339 | 0.870 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2022 | 195 | 0.780 |
Why?
|
| Blood Glucose | 9 | 2017 | 6259 | 0.770 |
Why?
|
| Liver | 13 | 2022 | 7472 | 0.770 |
Why?
|
| Gluconeogenesis | 2 | 2017 | 183 | 0.710 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2019 | 30 | 0.680 |
Why?
|
| Pentacyclic Triterpenes | 4 | 2019 | 37 | 0.630 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2022 | 11732 | 0.600 |
Why?
|
| Body Weight | 2 | 2019 | 4666 | 0.580 |
Why?
|
| Withanolides | 1 | 2016 | 12 | 0.570 |
Why?
|
| Hypothalamus | 4 | 2016 | 1063 | 0.550 |
Why?
|
| Insulin Receptor Substrate Proteins | 5 | 2013 | 563 | 0.550 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 252 | 0.520 |
Why?
|
| DNA-Binding Proteins | 5 | 2014 | 9647 | 0.500 |
Why?
|
| Lipogenesis | 1 | 2016 | 212 | 0.490 |
Why?
|
| Insulin | 10 | 2014 | 6583 | 0.470 |
Why?
|
| Transcription Factors | 7 | 2014 | 12207 | 0.460 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 130 | 0.450 |
Why?
|
| Phenylbutyrates | 3 | 2009 | 69 | 0.440 |
Why?
|
| Eating | 1 | 2019 | 1538 | 0.430 |
Why?
|
| Weight Loss | 2 | 2024 | 2622 | 0.420 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2011 | 25 | 0.410 |
Why?
|
| Lactation | 1 | 2014 | 412 | 0.390 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2013 | 2848 | 0.380 |
Why?
|
| Taurochenodeoxycholic Acid | 2 | 2009 | 34 | 0.370 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 508 | 0.360 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2010 | 127 | 0.360 |
Why?
|
| Serine | 1 | 2013 | 828 | 0.360 |
Why?
|
| Multiprotein Complexes | 2 | 2013 | 1119 | 0.350 |
Why?
|
| Mice | 25 | 2024 | 81178 | 0.340 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2014 | 736 | 0.330 |
Why?
|
| Animals | 32 | 2024 | 168788 | 0.330 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 697 | 0.320 |
Why?
|
| Fatty Acids | 1 | 2016 | 1808 | 0.320 |
Why?
|
| Signal Transduction | 12 | 2022 | 23404 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 12 | 2019 | 21824 | 0.290 |
Why?
|
| Phosphorylation | 7 | 2021 | 8437 | 0.290 |
Why?
|
| Receptors, Leptin | 2 | 2024 | 360 | 0.290 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2013 | 2108 | 0.280 |
Why?
|
| Cell Nucleus | 2 | 2014 | 2969 | 0.250 |
Why?
|
| Hyperglycemia | 1 | 2014 | 1372 | 0.250 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 1613 | 0.230 |
Why?
|
| Stress, Physiological | 1 | 2010 | 1404 | 0.220 |
Why?
|
| eIF-2 Kinase | 3 | 2008 | 150 | 0.200 |
Why?
|
| Mitochondria | 1 | 2013 | 3520 | 0.180 |
Why?
|
| Receptor, Insulin | 4 | 2011 | 846 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 2938 | 0.180 |
Why?
|
| Glucose Tolerance Test | 3 | 2016 | 1150 | 0.180 |
Why?
|
| YY1 Transcription Factor | 1 | 2019 | 60 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 2 | 2011 | 77 | 0.160 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 12075 | 0.160 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2019 | 297 | 0.150 |
Why?
|
| HEK293 Cells | 2 | 2019 | 4201 | 0.150 |
Why?
|
| Tunicamycin | 2 | 2009 | 112 | 0.150 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2016 | 43 | 0.140 |
Why?
|
| Neurons | 2 | 2013 | 9335 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 644 | 0.130 |
Why?
|
| Tripterygium | 1 | 2015 | 16 | 0.130 |
Why?
|
| Cell Line | 3 | 2017 | 15999 | 0.130 |
Why?
|
| Apoptosis | 3 | 2008 | 9728 | 0.130 |
Why?
|
| Protein Stability | 1 | 2016 | 557 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2011 | 1157 | 0.120 |
Why?
|
| Cells, Cultured | 5 | 2017 | 19227 | 0.120 |
Why?
|
| Islets of Langerhans | 4 | 2005 | 1350 | 0.120 |
Why?
|
| Protein Kinases | 1 | 2021 | 1639 | 0.120 |
Why?
|
| Weight Gain | 1 | 2024 | 2292 | 0.120 |
Why?
|
| Mice, Knockout | 7 | 2019 | 14556 | 0.110 |
Why?
|
| Glucose Intolerance | 2 | 2010 | 577 | 0.110 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 985 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 874 | 0.100 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2011 | 25 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2505 | 0.100 |
Why?
|
| Plant Extracts | 1 | 2015 | 472 | 0.100 |
Why?
|
| Phosphoproteins | 3 | 2005 | 2440 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2016 | 5180 | 0.100 |
Why?
|
| Protein Subunits | 1 | 2014 | 960 | 0.090 |
Why?
|
| Drug Therapy | 1 | 2013 | 497 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 443 | 0.090 |
Why?
|
| Hydrolysis | 1 | 2011 | 682 | 0.090 |
Why?
|
| Autophagy | 2 | 2021 | 1300 | 0.090 |
Why?
|
| Protein Binding | 2 | 2019 | 9392 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 18027 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 647 | 0.080 |
Why?
|
| Epinephrine | 1 | 2012 | 793 | 0.080 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 809 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2013 | 742 | 0.080 |
Why?
|
| Male | 12 | 2019 | 350027 | 0.080 |
Why?
|
| Protein Transport | 1 | 2013 | 1989 | 0.080 |
Why?
|
| Gene Expression | 2 | 2019 | 7799 | 0.080 |
Why?
|
| Chromatography, Liquid | 1 | 2011 | 977 | 0.080 |
Why?
|
| Receptors, Pituitary Hormone | 1 | 2007 | 29 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2021 | 2776 | 0.070 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2007 | 41 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2010 | 1682 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 1866 | 0.070 |
Why?
|
| Hypoglycemic Agents | 2 | 2017 | 2875 | 0.070 |
Why?
|
| Hypothalamic Hormones | 1 | 2007 | 147 | 0.070 |
Why?
|
| Pituitary Hormones | 1 | 2007 | 183 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 16687 | 0.070 |
Why?
|
| Fasting | 1 | 2012 | 1591 | 0.070 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2006 | 190 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2010 | 1539 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 7723 | 0.060 |
Why?
|
| RNA Interference | 1 | 2014 | 2890 | 0.060 |
Why?
|
| Melanins | 1 | 2007 | 289 | 0.060 |
Why?
|
| Protein Multimerization | 1 | 2010 | 971 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 3505 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2006 | 452 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 3133 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 11368 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2015 | 2895 | 0.060 |
Why?
|
| Adipose Tissue | 2 | 2006 | 3278 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2008 | 1097 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6367 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2019 | 4217 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 1888 | 0.050 |
Why?
|
| Humans | 11 | 2022 | 744220 | 0.050 |
Why?
|
| Dietary Fats | 2 | 2007 | 2017 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2011 | 4156 | 0.050 |
Why?
|
| Diet | 1 | 2019 | 7937 | 0.050 |
Why?
|
| Sirolimus | 1 | 2008 | 1563 | 0.050 |
Why?
|
| Mutation | 3 | 2011 | 29784 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2014 | 13036 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2006 | 3701 | 0.050 |
Why?
|
| Mesangial Cells | 1 | 2019 | 24 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2002 | 390 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 1284 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2021 | 231 | 0.040 |
Why?
|
| Insulin-Secreting Cells | 1 | 2007 | 891 | 0.040 |
Why?
|
| Lignans | 1 | 2019 | 81 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9438 | 0.040 |
Why?
|
| Hyperinsulinism | 1 | 2002 | 415 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 871 | 0.040 |
Why?
|
| Furans | 1 | 2019 | 194 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 2915 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2017 | 117 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2008 | 3085 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 377 | 0.040 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2017 | 147 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 6386 | 0.030 |
Why?
|
| Base Sequence | 2 | 2019 | 12801 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 1085 | 0.030 |
Why?
|
| Female | 3 | 2019 | 380197 | 0.030 |
Why?
|
| Proteins | 1 | 2008 | 6101 | 0.030 |
Why?
|
| Liver Glycogen | 1 | 2012 | 34 | 0.030 |
Why?
|
| Pregnancy | 1 | 2014 | 29142 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 5755 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 945 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2017 | 1210 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 5853 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 4935 | 0.020 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2005 | 744 | 0.020 |
Why?
|
| Rats | 1 | 2004 | 24273 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 5867 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2004 | 7879 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 2892 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2012 | 1725 | 0.020 |
Why?
|
| DNA | 1 | 2019 | 7303 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2008 | 40992 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13668 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4752 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2005 | 2916 | 0.010 |
Why?
|
| Chromans | 1 | 2003 | 122 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13280 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2003 | 791 | 0.010 |
Why?
|
| Cell Size | 1 | 2003 | 643 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2002 | 642 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 2003 | 9735 | 0.010 |
Why?
|
| Thiazolidinediones | 1 | 2003 | 476 | 0.010 |
Why?
|
| Neoplasms | 1 | 2008 | 21672 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 1312 | 0.010 |
Why?
|
| Cell Separation | 1 | 2003 | 1751 | 0.010 |
Why?
|
| Exons | 1 | 2003 | 2439 | 0.010 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2003 | 1121 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 4567 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 2014 | 0.010 |
Why?
|
| Calcium | 1 | 2007 | 5757 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 5974 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10949 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 7183 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 12781 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2005 | 10480 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2003 | 11478 | 0.000 |
Why?
|
| Time Factors | 1 | 2003 | 40063 | 0.000 |
Why?
|
Concepts
(194)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_